12:00 AM
 | 
Aug 08, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

BNC105: Interim Phase II data

Interim data from a single-arm, Australian Phase II trial in 24 evaluable patients who progressed after first-line chemotherapy with Alimta pemetrexed and cisplatin showed that second-line treatment with...

Read the full 126 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >